Sensus Healthcare Stock News

Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passe

Biotech has been the worst performing sector of the stock market across the past 12 months.

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Sensus Healthcare Inc (NASDAQ: SRTS ) sold its Sculptura assets to Empyrean Medical Systems for $15 million in cash . The sale included an inventory of Sculptura systems and parts, in addition to all related intellectual property. The Sculptura system provides targeted Directional Anisotropic Radiation Therapy (ART) and brachytherapy utilizing proprietary, state-of-the-art 3D Beam … Full story available on Benzinga.com

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion

In last trading session, Sensus Healthcare Inc. (NASDAQ:SRTS) saw 0.51 million shares changing hands with its beta currently measuring 0.33. Company’s recent per share price level of $10.67 trading at $0.75 or 7.56% at ring of the bell on the day assigns it a market valuation of $173.71M. That closing price of SRTS’s stock is … 12-Month Price Target For Sensus Healthcare Inc. (NASDAQ:SRTS) Now Sits At $17.50 Read More »

Sensus Healthcare Inc. (NASDAQ:SRTS) shares, rose in value on Friday, 02/18/22, with the stock price up by 2.04% to the previous days close as strong demand from buyers drove the stock to $10.49. Actively observing the price movement in the last trading, the stock closed the session at $10.28, falling within a range of $9.89 What Analysts Were Expecting After Sensus Healthcare Inc. (NASDAQ: SRTS) rose 2.04% Read More »

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our

Keybanc cut Autodesk, Inc. (NASDAQ: ADSK) price target from $350 to $300. Autodesk shares fell 1.5% to $223.77 in pre-market trading. Raymond James raised CVS Health Corporation (NYSE: CVS) price

Sensus Healthcare Inc''s (NASDAQ: SRTS ) Q4 FY21 sales increased 156% to $13 million , primarily driven by a higher number of units sold as the market continued to reopen, beating the consensus of $11.7 million. The gross profit margin improved to 68% of revenues, compared with $3.2 million, or 63.4% of revenues. The Company shipped a record 35 systems, including three … Full story available on Benzinga.com

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the s

Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q4 2021 Results - Earnings Call Transcript